• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Immunohistochemical and Electron Microscopy Evolution in the Diagnosis of Lung Cancer in Iraq.伊拉克肺癌的免疫组化和电子显微镜诊断演变。
Arch Razi Inst. 2022 Feb 28;77(1):95-100. doi: 10.22092/ARI.2021.356552.1870. eCollection 2022 Feb.
2
Complementary value of electron microscopy and immunohistochemistry in the diagnosis of non-small cell lung cancer: A potential role for electron microscopy in the era of targeted therapy.电子显微镜检查与免疫组织化学在非小细胞肺癌诊断中的互补价值:电子显微镜检查在靶向治疗时代的潜在作用。
Ultrastruct Pathol. 2019;43(6):237-247. doi: 10.1080/01913123.2019.1692118. Epub 2019 Dec 6.
3
Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer.手术切除的非小细胞肺癌中p53和p16免疫组化表达的预后预测
Eur J Cardiothorac Surg. 2003 Feb;23(2):221-8. doi: 10.1016/s1010-7940(02)00749-2.
4
Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance.非小细胞肺癌淋巴结中的微转移P53阳性细胞:预后意义
J Thorac Cardiovasc Surg. 1997 Sep;114(3):339-46. doi: 10.1016/S0022-5223(97)70178-8.
5
Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.程序性细胞死亡配体1(PD-L1)、CD8 +肿瘤浸润淋巴细胞和p53在非小细胞肺癌中的预后意义:一项免疫组织化学研究
Turk Patoloji Derg. 2017;1(1):211-222. doi: 10.5146/tjpath.2017.01398.
6
Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.p53、HER-2/neu和bcl-2免疫组化表达在Ⅰ期非小细胞肺癌中的预后价值
Hum Pathol. 2002 Jan;33(1):105-10. doi: 10.1053/hupa.2002.30183.
7
Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study).免疫组织化学评估非小细胞肺癌生物标志物表达(Pharmacogenoscan 研究)。
Lung Cancer. 2014 Feb;83(2):182-8. doi: 10.1016/j.lungcan.2013.12.003. Epub 2013 Dec 21.
8
Prognostic role of serum p53 antibodies in lung cancer.血清p53抗体在肺癌中的预后作用。
BMC Cancer. 2015 Mar 18;15:148. doi: 10.1186/s12885-015-1174-4.
9
Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in Lung Cancer.评估抑癌基因 p53 翻译后修饰和 TTC5 共因子在肺癌中的作用。
Int J Mol Sci. 2021 Dec 7;22(24):13198. doi: 10.3390/ijms222413198.
10
The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.p53和bcl-2在肺腺癌中的表达的预后意义及其与Ki-67增殖分数的相关性。
Cancer. 1997 Sep 15;80(6):1034-45.

引用本文的文献

1
Evaluation of MicroRNA as Minimal Residual Disease in Leukemia: Diagnostic and Prognostic Approach: A Review.微小RNA作为白血病微小残留病的评估:诊断与预后方法:综述
Iran J Public Health. 2023 Dec;52(12):2541-2553. doi: 10.18502/ijph.v52i12.14315.

本文引用的文献

1
Cancer Statistics for Hispanics/Latinos, 2018.2018 年西班牙裔/拉丁裔癌症统计数据。
CA Cancer J Clin. 2018 Nov;68(6):425-445. doi: 10.3322/caac.21494. Epub 2018 Oct 4.
2
Immunohistochemistry for predictive biomarkers in non-small cell lung cancer.非小细胞肺癌预测生物标志物的免疫组织化学
Transl Lung Cancer Res. 2017 Oct;6(5):570-587. doi: 10.21037/tlcr.2017.07.06.
3
Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.免疫组织化学在肺生物标志物检测中的应用:来自肺病理学学会成员的观点。
Arch Pathol Lab Med. 2018 Mar;142(3):408-419. doi: 10.5858/arpa.2017-0106-SA. Epub 2017 Jul 7.
4
Lung cancer in Basrah, Iraq during 2005-2012. Incidence and time trend.2005 - 2012年伊拉克巴士拉的肺癌。发病率及时间趋势。
Saudi Med J. 2016 Nov;37(11):1214-1219. doi: 10.15537/smj.2016.11.16269.
5
ROS1 copy number alterations are frequent in non-small cell lung cancer.ROS1基因拷贝数改变在非小细胞肺癌中很常见。
Oncotarget. 2016 Feb 16;7(7):8019-28. doi: 10.18632/oncotarget.6921.
6
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
7
Estrogen Receptor Gene Polymorphisms and Lung Adenocarcinoma Risk in Never-Smoking Women.雌激素受体基因多态性与不吸烟女性肺腺癌风险。
J Thorac Oncol. 2015 Oct;10(10):1413-20. doi: 10.1097/JTO.0000000000000646.
8
The prevalence of smoking among karbala/iraq university students in iraq in 2005.2005年伊拉克卡尔巴拉/伊拉克大学生中的吸烟率。
Tob Use Insights. 2014 Feb 10;7:9-14. doi: 10.4137/TUI.S12238. eCollection 2014.
9
Cancer trends in Lebanon: a review of incidence rates for the period of 2003-2008 and projections until 2018.黎巴嫩的癌症趋势:2003-2008 年发病率的回顾以及 2018 年的预测。
Popul Health Metr. 2014 Mar 4;12(1):4. doi: 10.1186/1478-7954-12-4.
10
Lung cancer in women: a single institution experience with 50 patients.女性肺癌:一家机构对50例患者的经验
Asian Pac J Cancer Prev. 2014;15(1):151-4. doi: 10.7314/apjcp.2014.15.1.151.

伊拉克肺癌的免疫组化和电子显微镜诊断演变。

Immunohistochemical and Electron Microscopy Evolution in the Diagnosis of Lung Cancer in Iraq.

机构信息

Department of Anatomy, College of Medicine, University of Babylon, Babylon, Iraq.

出版信息

Arch Razi Inst. 2022 Feb 28;77(1):95-100. doi: 10.22092/ARI.2021.356552.1870. eCollection 2022 Feb.

DOI:10.22092/ARI.2021.356552.1870
PMID:35891773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9288611/
Abstract

Lung cancer is considered the most commonly diagnosed cancer that kills over 1.76 million people yearly around the world. This study aimed to investigate how electron microscopy (EM) and immunohistochemistry (IHC) worked together. In the current study, a total of 50 tissue blocks were used which were embedded in paraffin wax from 20 healthy controls and 30 lung cancer patients (19 males and 11 females) to conduct a histopathological examination, which included hematoxylin and eosin stain, IHC detection regarding the protein expression in P53, and EM for lung cancer diagnosis. The findings indicated that the mean age of the patients was 51.84±15.70 years, and there was no correlation between the age of patients and the disease stage. P53 expression was measured using an immunohistochemical technique, while the positive rate showed a highly significant difference between healthy controls and patients (P≤0.05). The association of P53 expression with age and gender was not significant, although it showed a significant correlation with stage and grade. Furthermore, a correlation was found between P53 IHC and EM (≤0.05). In conclusion, the detection of an immunohistochemical method of lung cancer patients has been (gold standard) useful in detecting the subsets of patients in addition to a good method of EM in the diagnosis of lung cancer patients.

摘要

肺癌是全球最常见的癌症,每年导致超过 176 万人死亡。本研究旨在探讨电子显微镜 (EM) 和免疫组织化学 (IHC) 如何协同工作。在当前研究中,共使用了 50 个组织块,这些组织块来自 20 名健康对照者和 30 名肺癌患者(19 名男性和 11 名女性)的石蜡包埋组织,进行组织病理学检查,包括苏木精和伊红染色、P53 蛋白表达的 IHC 检测以及用于肺癌诊断的 EM。研究结果表明,患者的平均年龄为 51.84±15.70 岁,患者年龄与疾病分期之间无相关性。使用免疫组织化学技术测量 P53 表达,阳性率在健康对照组和患者组之间存在显著差异 (P≤0.05)。P53 表达与年龄和性别之间无显著关联,但与分期和分级呈显著相关。此外,还发现 P53 IHC 与 EM 之间存在相关性 (P≤0.05)。总之,对肺癌患者进行免疫组织化学方法检测已成为(金标准)有用的方法,除了 EM 是诊断肺癌患者的好方法之外,还可以检测患者的亚群。